2021
DOI: 10.1016/j.bjps.2021.03.092
|View full text |Cite
|
Sign up to set email alerts
|

Association between duration of peripheral facial palsy, severity, and age of the patient, and psychological distress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(10 citation statements)
references
References 27 publications
1
9
0
Order By: Relevance
“…The overall population that was above 55 years of age was associated with moderate depression, linking depression with the severity of the disease by applying the Hospital Anxiety and Depression Scale (HADS). [25] 50.8% of the patients reported scoring between 11 and 15 on the HADS scale who had paralysis for less than 5 years. In a more comprehensive study, 6 studies were scrutinized in a reviewed by Dr. J. Fuzi, and ultimately found that there is a positive trend in the improvement of facial paresis through the administration of botulinum toxin type A.…”
Section: Evaluation Of Risks Of Treating Peripheral Facial Paralysis ...mentioning
confidence: 99%
See 1 more Smart Citation
“…The overall population that was above 55 years of age was associated with moderate depression, linking depression with the severity of the disease by applying the Hospital Anxiety and Depression Scale (HADS). [25] 50.8% of the patients reported scoring between 11 and 15 on the HADS scale who had paralysis for less than 5 years. In a more comprehensive study, 6 studies were scrutinized in a reviewed by Dr. J. Fuzi, and ultimately found that there is a positive trend in the improvement of facial paresis through the administration of botulinum toxin type A.…”
Section: Evaluation Of Risks Of Treating Peripheral Facial Paralysis ...mentioning
confidence: 99%
“…[24] There was another study where a positive correlation was found between moderate depression and the length of on-set peripheral facial palsy. [25] Furthermore, another clinical experiment made by Dr. Mehta was done in efforts to measure the improvement in patients with facial paralysis after the administration of BtA injections. The study was held at an outpatient clinic that treats facial nerve paralysis and suggested that the general use of botulinum toxin type A has a stable benefit in controlling facial nerve palsies and has a statistically significant improvements in the quality of life.…”
Section: Evaluation Of Risks Of Treating Peripheral Facial Paralysis ...mentioning
confidence: 99%
“…[ 3 ] These symptoms make social communication difficult for patients and decrease their quality of life, frequently leading to significant psychological disorders such as anxiety and depression. [ 4 ] Therefore, it is important to focus not only on treating the functional problem of facial palsy, but also improving the patient’s psychological condition.…”
Section: Introductionmentioning
confidence: 99%
“…FP shows an annual incidence rate of up to 40 cases per 100,000 population with equal rates in male and female patients [ 4 , 5 , 6 ]. The mean age of onset ranges from 45–56 years of age [ 7 , 8 ]. Depending on the lesion localization, FP can be caused by trauma, or following viral or bacterial infections (e.g., HSV-1, VZV, Lyme disease), neoplasms, or surgery [ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%